Cantabio Pharmaceuticals Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 7
Employees
  • Stock Symbol
  • CTBO
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $25.00
  • (As of Thursday Closing)

Cantabio Pharmaceuticals General Information

Description

Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commercializing novel therapies and the intellectual property generated from its research and development activities for Parkinson's disease and Alzheimer's disease and other related diseases. In addition, In addition, it is also engaged in the development of therapeutic proteins that can pass through the blood-brain barrier and supplement in vivo levels of proteins which display loss of function during disease conditions.

Contact Information

Formerly Known As
Gardedam Therapeutics
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
  • 2225 East Bayshore Road
  • Palo Alto, CA 94303
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cantabio Pharmaceuticals Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$25.00 $25.00 $10.50 - $244.00 $564K 22.5K 60.41 -$200.00

Cantabio Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 31-Dec-2018 FY 2018 31-Mar-2018 FY 2017 31-Mar-2017 FY 2016 31-Mar-2016
EV 2,316 3,324 4,189 53,509
Revenue 0 0 0 0
EBITDA (331) (1,392) (1,072) (751)
Net Income (1,543) (2,012) (1,112) (751)
Total Assets 326 109 34 52
Total Debt 1,409 1,205 369 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cantabio Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cantabio Pharmaceuticals‘s full profile, request access.

Request a free trial

Cantabio Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cantabio Pharmaceuticals Inc is the United States based preclinical stage biotechnology company. It is focused on commer
Biotechnology
Palo Alto, CA
7 As of 2018
000000000000

0000000

ore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi
0000 000000000
Framingham, MA
00 As of 0000
000.00
0000000000 000.00

00000000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
0000000000000
South San Francisco, CA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cantabio Pharmaceuticals Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alzheon Venture Capital-Backed Framingham, MA 00 000.00 0000000000 000.00
000000000 Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
0000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
0000000 00000000 Formerly VC-backed Cambridge, MA 00 00000 000000 - 000 00000
0000000 Corporation Glostrup, Denmark 00 000.00 000000000 000.00
You’re viewing 5 of 20 competitors. Get the full list »

Cantabio Pharmaceuticals Executive Team (3)

Name Title Board Seat Contact Info
Gergely Tóth Ph.D Founder & Chief Executive Officer
Simon Peace Chief Accounting Officer, Accounting
Thomas Roger Sawyer Ph.D Chief Operating Officer
To view Cantabio Pharmaceuticals’s complete executive team members history, request access »

Cantabio Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cantabio Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000000000 00 18-Dec-2015 000000000000000000 Consulting Services (B2B) 0000000 0ó00 00.0
To view Cantabio Pharmaceuticals’s complete acquisitions history, request access »